Specialty Program
Cardiac Amyloidosis Program
A dedicated diagnostic and care pathway for patients with suspected or confirmed cardiac amyloidosis — combining advanced imaging, nuclear cardiology and ongoing specialist follow-up.
Cardiac amyloidosis is an under-recognised cause of heart failure, arrhythmia and unexplained left ventricular thickening. Early, accurate diagnosis is essential because modern, disease-modifying therapy can meaningfully change the course of the disease.
Our amyloidosis program is led by Dr. Handel Emery, with multidisciplinary input from internal medicine. We provide a structured pathway from initial suspicion through confirmation, staging and long-term monitoring.
When to refer
- Unexplained left ventricular hypertrophy on echocardiography
- Heart failure with preserved ejection fraction (HFpEF) in older adults
- Low-flow, low-gradient aortic stenosis
- Bilateral carpal tunnel syndrome with cardiac symptoms
- Persistent troponin or NT-proBNP elevation without clear cause
- Family history of transthyretin (ATTR) amyloidosis
Diagnostic pathway
What to expect
Specialist consultation
Comprehensive history, examination and risk assessment.
Echocardiography
Strain imaging and structural assessment to flag infiltrative disease.
Laboratory work-up
Serum free light chains, immunofixation and biomarkers.
Nuclear scintigraphy
Bone-avid tracer imaging when ATTR is suspected.
Medical emergency: If you are experiencing chest pain, severe shortness of breath, fainting, stroke symptoms, or another medical emergency, call 119 or go to the nearest emergency department.